Navigation Links
Newly Updated Pharmacy State Law Compendium Available
Date:10/8/2009

CORAL SPRINGS, Fla., Oct. 8 /PRNewswire/ -- The most comprehensive, up-to-date compendium of state and federal pharmacy statutes and regulations is now available from Point of Care Partners (POCP), a nationally known boutique healthcare information technology (HIT) strategy and management consulting firm with expertise in ePrescribing, chronic care management, electronic health records, health information exchanges and personal health records.

The compendium, updated for the third quarter of 2009, is a must-have for clinical software companies; policymakers; intermediaries; retail, mail and specialty pharmacies, and others who need to have the latest state-specific information on the changing regulatory landscape affecting ePrescribing and the exchange of prescription information across state lines. The timing for this updated compendium has never been better, given the wide variations and constant realignment of requirements among jurisdictions and Boards of Pharmacy (BOP) and the growing use of ePrescribing and health information exchange within and across states.

"Our pharmacy law database is invaluable to help ensure that clients can comply with state and federal ePrescribing regulations," said Sherry L. Neumann, PharmD, an affiliated consultant with POCP who created the compendium and has updated it every quarter since 2006.

The new database has the most currently available information as of the third quarter of 2009, which is gleaned from BOP websites and other published materials, such as pharmacy association and BOP newsletters, state health and safety codes, and Medicaid rules and regulations (where applicable). It includes:

  • State-by-state citations of the rules, regulations and statutes pertaining to electronically transmitted, faxed or printed prescriptions
  • Authentication requirements for faxed prescriptions
  • Addresses, Web sites and contact information
  • Actionable spreadsheet summarizing each Board's requirements
  • Indication of which states require written and/or in-person approval

"State pharmacy-related regulations and statutes are forever changing and are often ambiguous. That's why persistent monitoring and in-depth analysis are critical," said Tony Schueth, POCP's founder and managing partner. "POCP is in a unique position to interpret and analyze the rules and regulations and to work with clients to utilize the information to further their business goals."

In addition to the compendium and its quarterly updates, Dr. Neumann and other POCP staff are available to create value-driven assessments, as well as drill down on issues specific to individual market situations, to assist product development and implementation teams. For additional information, call Tony Schueth at 954-346-1999.

SOURCE Point of Care Partners


'/>"/>
SOURCE Point of Care Partners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
4. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
5. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
6. Newly Approved HIV Drug Shows Great Promise
7. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
8. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
9. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):